Abstract
The present work describes a stability-indicating HPTLC method for simultaneous analysis of Amlodipine besilate (AMLO), Losartan Potassium (LOS) and Hydrochlorothiazide (HCTZ) in bulk and pharmaceutical dosage form. Aluminium plate precoated with silica gel 60 F 254 was used as stationary phase. The separation was carried out using chloroform: ethyl acetate: methanol: ammonia (4: 4: 2:0.2 v/v/v/v) as mobile phase. The densitometric scanning was carried out at 232 nm. The linearity was obtained in the range 100-800 ng per band for amlodipine besilate (Correlation coefficient: 0.9954), 400-2400 ng per band for hydrochlorothiazide (Correlation coefficient: 0.9952) and 1000-8000 ng per band for losartan potassium (Correlation coefficient: 0.9947). The method was validated as per ICH guidelines. The combined dose tablet formulation was subjected to forced degradation by acid, alkali, oxidation, dry heat and exposure to ultraviolet radiations at 254 nm. The degradation products were well resolved from the pure drug with significantly different R f values.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
